Robert Essner

Insider Reports History

SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Robert Essner
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Robert Essner

Form 4 holding Director

Organon & Co.

Security class
Phantom Stock
Shares / value
81,141
Estimated value
$629,534
Report date
12 Jun 2026
Price
$10.04
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

AMICUS THERAPEUTICS, INC.

Security class
Common Stock
Shares / value
31,115
Estimated value
$384,647
Report date
10 Jun 2021
Price
$12.36
Ownership
Direct
Form 4 holding Director

AMICUS THERAPEUTICS, INC.

Security class
Stock Options (right to buy)
Shares / value
36,111
Estimated value
Report date
10 Jun 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Robert Essner

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .